. . . . . . . "[Furthermore, treating the RA-CPCs with the anti-human IL-17 antibody secukinumab or the anti-TNF-? antibody adalimumab reduced the proinflammatory IL-6 protein level and positively influenced the secretion of anti-inflammatory IL-10 protein.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en . . . . . "2017-02-19"^^ . . "Gene-disease associations inferred from text-mining the literature."@en . "DisGeNET evidence - LITERATURE"@en . "2017-10-17T13:16:48+02:00"^^ . . . . . . . . . . . "v5.0.0.0" . "v5.0.0" .